Market Overview

Benzinga's Top Pre-Market Losers

Related IPXL
Impax Announces Departure of Carole Ben-Maimon, M.D., President of Global Pharmaceuticals
Benzinga's Top Initiations
Middle-Market Deal Making Surges in First Three Quarters (Fox Business)
Related JCP
Morgan Stanley: Consumers Choosing Restaurants, iPhones Over Apparel
The rise of bricks and mortar commerce
JCP Names President, CEO Designee (Fox Business)

Impax Laboratories (NASDAQ: IPXL) dipped 21.00% to $15.80 in the pre-market session. Impax Laboratories reported that the FDA completed its re-inspection of its Hayward manufacturing facility. At the conclusion of this inspection, the FDA issued a new Form 483 with 12 observations.

Hospira (NYSE: HSP) shares dropped 4.10% to $28.55 in pre-market trading. Hospira's trailing-twelve-month ROE is 1.48%.

J.C. Penney Co (NYSE: JCP) shares fell 3.82% to $16.10 in the pre-market trading on reports that a stakeholder is selling a large block of shares in the retailer.

Weyerhaeuser Co (NYSE: WY) dipped 3.17% to $29.00 in the pre-market session. Weyerhaeuser's PEG ratio is 5.65.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (IPXL + HSP)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional